Defibrillator Devices And Equipment Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Defibrillator devices and equipment are used in the emergency treatment of life-threatening cardiac arrhythmias and abnormal heart rhythms by giving a high-energy electrical shock to the heart through the chest wall to restore its normal rhythm function.

Sizing and Forecast
The defibrillator devices and equipment market size has grown strongly in recent years. It will grow from <b>$10.9 billion in 2023 to $11.97 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. </b> The growth in the historic period can be attributed to cardiac arrest prevalence, aging population, emergency medical services (ems) integration, public awareness and training.

The defibrillator devices and equipment market size is expected to see strong growth in the next few years. It will grow to <b>$16.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. </b> The growth in the forecast period can be attributed to personalized medicine, telehealth integration, global access to healthcare, bystander intervention and public access defibrillation. Major trends in the forecast period include wearable defibrillators, next-generation aeds, subcutaneous icds (s-icds), pediatric defibrillation.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Segmentation & Regional Insights
The defibrillator devices and equipment market covered in this report is segmented –

1) By Type: Implantable Defibrillators, External defibrillators
2) By Implantable Defibrillators: Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), Cardiac Resynchronization Therapy- Defibrillator (CRT-D), Single & Dual Chamber
3) By External defibrillators: Manual External Defibrillator (MEDs), Automated External Defibrillator (AEDs), Wearable Cardioverter Defibrillator (WCDs)
4) By End User: Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home Healthcare

<b>North America</b> was the largest region in the global defibrillator devices and equipment market in 2023. <b>Western Europe</b> was the second-largest region in the defibrillator devices and equipment market. The regions covered in the defibrillator devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2538&type=smp

Major Driver Impacting Market Growth
Increasing healthcare expenditure is expected to propel the growth of the defibrillator devices and equipment market going forward. Healthcare expenditure refers to the amount of money spent on healthcare goods and services, including personal health care, public health activities, health research, and health insurance programs. Healthcare expenditure can help increase the adoption of defibrillator devices in hospitals, clinics, and public access defibrillation programs. For instance, according to the National Health Expenditure Account (NHEA), published by the Centers for Medicare and Medicaid Services, a US-based federal agency, U.S. healthcare spending grew 2.7% in 2021, reaching $4.3 trillion or $12,914 per person. Thus, enhanced healthcare infrastructure is driving the growth of the defibrillator devices and equipment market.

Key Industry Players
Major companies operating in the defibrillator devices and equipment market include <b> Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V, ZOLL Medical Corporation, Cardiac Science Corporation, Physio-Control Inc., Nihon Kohden Corporation, Defibtech LLC, Schiller AG, Biotronik Inc., LivaNova plc, HeartSine Technologies LLC, Mindray Medical International Limited, Metrax Engineering Ltd., CU Medical Systems Inc., Fukuda Denshi Co. Ltd., GE Healthcare, Innomed Technologies Inc., Progetti Srl, Stryker Corporation, Welch Allyn Inc., Weinmann Emergency Medical Technology GmbH + Co. KG, Bexen Cardio, GCE Group, Lepu Medical Technology (Beijing) Co. Ltd., Shenzhen XFT Medical Limited, Zhejiang Medtec Medical Devices Co. Ltd. </b>

The defibrillator devices and equipment market report table of contents includes:

1. Executive Summary
2.Defibrillator Devices And Equipment Market Characteristics
3.Defibrillator Devices And Equipment Market Trends And Strategies
4.Defibrillator Devices And Equipment market analysis
5. Defibrillator Devices And Equipment Market Size And Growth
6.Defibrillator Devices And Equipment Segmentation
7.Defibrillator Devices And Equipment Regional And Country Analysis
.
.
.
27.Defibrillator Devices And Equipment Competitive Landscape And Company Profiles
28.Defibrillator Devices And Equipment Key Mergers And Acquisitions
29.Defibrillator Devices And Equipment Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Koninklijke Philips N.V
• ZOLL Medical Corporation

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model